Stay updated on I-SPY Trial: Personalized Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.

Latest updates to the I-SPY Trial: Personalized Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA publication entry for Cemiplimab and Fianlimab with neoadjuvant chemotherapy in early-stage ERBB2-negative breast cancer (I-SPY2) was updated to include online-ahead-of-print status and the e262576 article number, replacing the previous citation.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, representing a minor update to the Study Details page.SummaryDifference0.0%

- Check23 days agoChange DetectedA medRxiv preprint by Magbanua et al. on circulating tumor DNA as a prognostic factor in neoadjuvant breast cancer therapy was added to the Publications list, expanding the study's biomarker references.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now shows a 500 error page with a minimal HTML structure. The original study content and navigation were removed, leaving the page unavailable.SummaryDifference25%

- Check44 days agoChange DetectedA new publication citation has been added to the Publications section, listing authors and the JAMA Oncol article on Cemiplimab and Fianlimab with neoadjuvant chemotherapy in early-stage high-risk ERBB2-negative breast cancer (I-SPY2). This update expands the study's referenced literature and documents ongoing dissemination of trial findings.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a new page build. It does not change the displayed information or user experience.SummaryDifference0.0%

Stay in the know with updates to I-SPY Trial: Personalized Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.